renoprotection

renoprotection

Medtalk Any activity to minimize adverse effects–especially due to oxidative stress–on renal vasculature

renoprotection

Measures taken to prevent damage to the kidneys from any cause, IATROGENIC or otherwise.
References in periodicals archive ?
Renoprotection by alpha-Mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity.
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
Clinicians and researchers will find discussion of epidemiology, genetics, obesity, progression of proteinuria, advanced glycation end products, angiogenic factors, the Kallifrein-Kinin system, clinical trials for renoprotection, intensive glycemic control and renal outcome, antifibrotic treatment, and kidney regeneration, among other topics
We are uncertain whether there were anti-hypertensives given for other reasons such as renoprotection or cardioprotection or there were misclassification of controlled hypertensive as normotensive.
3 Although the use of agents that block the renin-angiotensinaldosterone system (RAAS) pathway lowers BP and is currently central to renoprotection in DN, the use of other agents to control BP is equally important.
ACE inhibitors and ARBs interrupt the renin angiotensin aldosterone system (RAAS) at different levels, and the combination of these classes of drugs may have an additive effect on albumin excretion and renoprotection.
These include neuroprotection, cardioprotection, renoprotection, and wound healing.
The new data suggest that routine administration of a fixed combination of perindopril and indapamide result in marked renoprotection and help preserve diabetic patients' kidney function, autonomy and quality of life, while potentially reducing the need for dialysis and kidney transplants.
24) On the other hand, some evidence suggests that the degree of renoprotection with antihypertensive therapy is directly proportional to the extent of blood pressure reduction.
Renoprotection in diabetes: genetic and nongenetic risk factors and treatment.
Finding ways to reduce organ dysfunction is an important goal in kidney transplantation, and these data suggest that renoprotection with HIF-PH inhibitors is a promising approach to achieve this therapeutic goal.